Personalized Obstructive Sleep Apnea Treatment and Effects on Alzheimer's Disease Biomarkers and Cognition Among Blacks
Recruiting · NCT06089161 · Interventional (participants receive a specific treatment) · Lead sponsor: University of Miami
View the official record on ClinicalTrials.gov →Interventions studied
Personalized OSA TreatmentStandard of Care
What this trial is about
The purpose of this research is to see how effective the Personalized obstructive sleep apnea (OSA) Treatment Adherence Model called PRAISE is in helping the patient stick to the physician recommended OSA treatment plan Positive Airway Pressure (PAP).
Who can take part
Age range
60 Years to 85 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Self-reported race/ethnicity as African American, African, Caribbean or black
- Ages 60-85 years
- accessible by phone
- OSA diagnosis
- consent, including permission to release medical data
Exclusion criteria
- progressive illnesses in which disability or death is expected within 1 year
- impaired cognitive/ functional ability precluding participation
- intention to move within the year
- and a family member currently enrolled.
Where it is running
1 location listed across 1 US state.
- University of Miami - Miami, Florida, United States